🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users administering products of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has removed violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.

After minutes of entering one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts show black plastic parcels with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service said it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly significant medical dangers”.